BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3287750)

  • 1. Microbiology and pharmacology of aztreonam.
    Duma RJ
    Urology; 1988 Jun; 31(6 Suppl):9-13. PubMed ID: 3287750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How and why aztreonam works.
    Rittenbury MS
    Surg Gynecol Obstet; 1990; 171 Suppl():19-23. PubMed ID: 2244291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem and aztreonam.
    Sobel JD
    Infect Dis Clin North Am; 1989 Sep; 3(3):613-24. PubMed ID: 2671142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
    Burgess DS; Summers KK; Hardin TC
    Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
    Malcangi A; Pesce S; Vitale M; Martinetto P
    G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglycosides, imipenem, and aztreonam.
    Johnson JG; Hardin TC
    Clin Podiatr Med Surg; 1992 Apr; 9(2):443-64. PubMed ID: 1586911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aztreonam, a new monobactam antimicrobial.
    Guay DR; Koskoletos C
    Clin Pharm; 1985; 4(5):516-26. PubMed ID: 3902330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of aztreonam in lower respiratory tract infections.
    Cook JL
    Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aztreonam--new antibiotic for treating infections caused by gram-negative aerobic bacteria].
    Szymkowiak J; Fojt E
    Wiad Lek; 1993; 46(1-2):56-61. PubMed ID: 8249381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UTIs and two new antibiotics in the elderly.
    Jones SR; Kimbrough R
    Geriatrics; 1988 Jul; 43(7):49-52, 55-8. PubMed ID: 3290058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aztreonam in treatment of intra-abdominal infections.
    Malangoni MA
    Urology; 1988 Jun; 31(6 Suppl):28-32. PubMed ID: 3287747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aztreonam: a review of the first monobactam.
    Westley-Horton E; Koestner JA
    Am J Med Sci; 1991 Jul; 302(1):46-9. PubMed ID: 2063887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro chemo-antibiotic sensitivity of gram-negative bacteria from various biological materials. Comparison between aztreonam and other agents].
    Monaci E; Monaci R; Giacalone G; Meoni S
    Minerva Med; 1987 May; 78(9):617-22. PubMed ID: 3587729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
    Raimondi A; Mattina R; Cocuzza CE
    Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
    Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
    Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aztreonam: clinical pharmacology.
    Stutman HR
    Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S104-8; discussion S128-32. PubMed ID: 2682507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the pharmacokinetics and pharmacodynamics of aztreonam.
    Ramsey C; MacGowan AP
    J Antimicrob Chemother; 2016 Oct; 71(10):2704-12. PubMed ID: 27334663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the development of beta-lactam antibiotics.
    Neu HC
    Scand J Infect Dis Suppl; 1984; 42():7-16. PubMed ID: 6597563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
    Honderlick P; Gravisse J; Dardelle D; Cahen P
    Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.